BCR and cancer: The characterization of the cellular program sustaining CLL cells proliferation after BCR engagement is a major step to understand mature B-cell leukemogenesis with the ultimate goal of developing innovative therapies targeting the nuclear response to BCR activation instead of the cytoplasmic pathways that can be bypassed in resistant cancer cells.